Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor
Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
Category:

Pharma News

  • Pharma News

    Could digital therapeutics provide a solution against opioid abuse?

    by Stephen Riddle November 2, 2022
    by Stephen Riddle November 2, 2022

    Digital therapeutics are rapidly coming into the foreground to treat a variety of conditions. Ben…

    Read more
  • Pharma News

    Omnichannel scientific engagement and the use of archetypes to drive personalization

    by Stephen Riddle November 1, 2022
    by Stephen Riddle November 1, 2022

    One of the greatest commodities in the healthcare industry is the provision of medically relevant…

    Read more
  • Pharma News

    14th Annual RNA Therapeutics Conference

    by Stephen Riddle November 1, 2022
    by Stephen Riddle November 1, 2022

    This post was originally published on Source Link

    Read more
  • Pharma News

    BMS announces positive Reblozyl phase 3 results for MDS

    by Stephen Riddle November 1, 2022
    by Stephen Riddle November 1, 2022

    Bristol Myers Squibb has announced positive topline results from its phase 3 trial of Reblozyl…

    Read more
  • Pharma News

    Pfizer says maternal RSV shot gives strong protection to newborns

    by Stephen Riddle November 1, 2022
    by Stephen Riddle November 1, 2022

    Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive…

    Read more
  • Pharma News

    Nicox glaucoma drug works, but not as well as hoped

    by Stephen Riddle November 1, 2022
    by Stephen Riddle November 1, 2022

    Nicox has had both good and bad news from a much-anticipated phase 3 trial of…

    Read more
  • Pharma News

    Lilly deepens bonds with Purdue University with new funding round

    by Stephen Riddle November 1, 2022
    by Stephen Riddle November 1, 2022

    Eli Lilly’s links to Purdue University go back a long way, and have been reinvigorated…

    Read more
  • Pharma News

    Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol

    by Stephen Riddle November 1, 2022
    by Stephen Riddle November 1, 2022

    In January 2020, the financial conglomerate Visa announced it was acquiring a relatively unknown startup,…

    Read more
  • Pharma News

    Anthropy 2022

    by Stephen Riddle October 31, 2022
    by Stephen Riddle October 31, 2022

    Between the 2nd and 4th November, a veritable who’s who of British industry will gather…

    Read more
  • Pharma News

    Verge Genomics takes AI-sourced drug for ALS into clinic

    by Stephen Riddle October 31, 2022
    by Stephen Riddle October 31, 2022

    Verge Genomics has joined a select group of biotechs who have taken a drug discovered…

    Read more
  • Pharma News

    AbbVie sheds autoimmune disease drug in blow to partner Inventiva

    by Stephen Riddle October 31, 2022
    by Stephen Riddle October 31, 2022

    Shares in French biotech Inventiva were on the slide this morning after AbbVie revealed that…

    Read more
  • Pharma News

    Regeneron’s Inmazeb named Galien’s Best Biotech Product

    by Stephen Riddle October 31, 2022
    by Stephen Riddle October 31, 2022

    The Galien Foundation, which acknowledges “extraordinary scientific innovations that improve the human condition”, has awarded…

    Read more
  • Pharma News

    Actinium eyes filing as conditioning drug for AML aces trial

    by Stephen Riddle October 31, 2022
    by Stephen Riddle October 31, 2022

    Actinium Pharma is on course to submit its targeted radiotherapy for acute myeloid leukaemia (AML)…

    Read more
  • Pharma News

    Fresenius’ new CEO starts strategic review as pressure rises

    by Stephen Riddle October 31, 2022
    by Stephen Riddle October 31, 2022

    When Michael Sen took over as chief executive of Fresenius at the start of this…

    Read more
  • Pharma News

    What makes a good (and bad) pharmaceutical forecast model

    by Stephen Riddle October 31, 2022
    by Stephen Riddle October 31, 2022

    Forecasting is essential in providing clarity on decision making about the future, but poor-quality forecasts…

    Read more
  • Pharma News

    Trial bias concern scuppers Y-mAbs brain cancer drug in FDA vote

    by Stephen Riddle October 30, 2022
    by Stephen Riddle October 30, 2022

    Shares in US biotech Y-mAbs Therapeutics have lost almost a third of their value after…

    Read more
  • Pharma News

    Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals

    by Stephen Riddle October 28, 2022
    by Stephen Riddle October 28, 2022

    In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help…

    Read more
  • Pharma News

    EU regulator lifts GSK amid torrid week for company’s pipeline

    by Stephen Riddle October 28, 2022
    by Stephen Riddle October 28, 2022

    The EMA has delivered some good news to GSK on a new long-acting HIV drug…

    Read more
  • Pharma News

    Boehringer taps Medidata e-clinical tech for another five years

    by Stephen Riddle October 28, 2022
    by Stephen Riddle October 28, 2022

    Boehringer Ingelheim was an early adopter of Medidata’s electronic data collection (EDC) platform for clinical…

    Read more
  • Pharma News

    Reuters Pharma 2022 – medical affairs and technology with Lance Hill

    by Stephen Riddle October 28, 2022
    by Stephen Riddle October 28, 2022

    During Reuters Pharma 2022, in Nice, France, pharmaphorum web editor Nicole Raleigh briefly spoke to…

    Read more
  • Pharma News

    FDA rejects Gilead’s hepatitis D therapy Hepcludex

    by Stephen Riddle October 28, 2022
    by Stephen Riddle October 28, 2022

    Gilead Sciences has been knocked back in its quest to bring the first drug therapy…

    Read more
  • Pharma News

    Making new product planning for life science more effective with human-centred design

    by Stephen Riddle October 28, 2022
    by Stephen Riddle October 28, 2022

    The sooner a human-centred perspective is applied to the development of either a drug or…

    Read more
  • Pharma News

    Alnylam scraps trial in rare eye disorder, blaming drug price reforms

    by Stephen Riddle October 28, 2022
    by Stephen Riddle October 28, 2022

    Alnylam has said it will not proceed with a clinical trial of its RNAi drug…

    Read more
  • Pharma News

    Santhera seeks speedy FDA review of Duchenne drug vamorolone

    by Stephen Riddle October 28, 2022
    by Stephen Riddle October 28, 2022

    Santhera has completed a rolling application for its Duchenne muscular dystrophy (DMD) therapy vamorolone in…

    Read more
  • Pharma News

    Deep Dive: Patients and Partnerships 2022

    by Stephen Riddle October 27, 2022
    by Stephen Riddle October 27, 2022

    The concept of patient centricity has been a key talking point across the healthcare ecosystem…

    Read more
  • Pharma News

    ESMO 2022 – PAOLA-1, ovarian cancer, and treatment innovation

    by Stephen Riddle October 27, 2022
    by Stephen Riddle October 27, 2022

    Last month, pharmaphorum had the chance to speak with Dr Isabelle Ray-Coquard, professor of medical…

    Read more
  • Pharma News

    FDA accepts review of SeresTx BLA for oral microbiome therapeutic

    by Stephen Riddle October 27, 2022
    by Stephen Riddle October 27, 2022

    The FDA has accepted for review Seres Therapeutics’ Biologics License Application (BLA) for SER-109, an…

    Read more
  • Pharma News

    Support bot for cancer patient relatives wins WHO Health Hackathon

    by Stephen Riddle October 27, 2022
    by Stephen Riddle October 27, 2022

    A bot that provide support to relatives of people with cancer – called Scally –…

    Read more
  • Pharma News

    Live from Frontiers Health 2022 – the pharmaphorum podcast

    by Stephen Riddle October 27, 2022
    by Stephen Riddle October 27, 2022

    In this special, live edition of the pharmaphorum podcast, recorded at the conclusion of Frontiers…

    Read more
  • Pharma News

    GSK’s shelves arthritis blockbuster hope otilimab after lacklustre data

    by Stephen Riddle October 27, 2022
    by Stephen Riddle October 27, 2022

    GSK has said it will not be able to move ahead with regulatory filings for…

    Read more
  • Pharma News

    New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry

    by Stephen Riddle October 27, 2022
    by Stephen Riddle October 27, 2022

    On 28 September 2022, the international and European self-regulatory bodies for the research-based pharmaceutical industry…

    Read more
  • Pharma News

    Seeking Ofev successor, Boehringer takes PDE4B drug into phase 3

    by Stephen Riddle October 27, 2022
    by Stephen Riddle October 27, 2022

    To proceed please enable Javascript (and Cookies) in your browser. Generic ViagraSildenafil Citrate 25/50/100/120/130/150/200mg Generic…

    Read more
  • Pharma News

    Pfizer and Flynn appeal £70m epilepsy drug fines in UK

    by Stephen Riddle October 26, 2022
    by Stephen Riddle October 26, 2022

    Drugmakers Pfizer and Flynn Pharma have formally launched an appeal against a £70 million ($84…

    Read more
  • Pharma News

    How one pharma “family business” places patients first

    by Stephen Riddle October 26, 2022
    by Stephen Riddle October 26, 2022

    When people think about pharma, they often think about “big” pharma: large, faceless corporations. But…

    Read more
  • Pharma News

    After setbacks for Roche and Sanofi, AZ scores oral SERD win

    by Stephen Riddle October 26, 2022
    by Stephen Riddle October 26, 2022

    AstraZeneca seems to have dodged the problems besetting other developers of oral selective estrogen receptor…

    Read more
  • Pharma News

    Normunity de-stealths, launches Series A immune normalisers

    by Stephen Riddle October 26, 2022
    by Stephen Riddle October 26, 2022

    Biotech start-up Normunity, Inc. has exited stealth with a $65 million Series A to create…

    Read more
  • Pharma News

    Neuraxpharm partners with mjn-neuro on epilepsy wearable

    by Stephen Riddle October 26, 2022
    by Stephen Riddle October 26, 2022

    German specialty drugmaker Neuraxpharm has licensed commercial rights in Europe to a wearable device developed…

    Read more
  • Pharma News

    J&J nabs FDA okay for BCMA bispecific Tecvayli

    by Stephen Riddle October 26, 2022
    by Stephen Riddle October 26, 2022

    Johnson & Johnson has secured another regulatory approval for its BCMAxCD3 bispecific antibody for multiple…

    Read more
  • Pharma News

    Ipsen faces yet another delay for rare disease drug in US

    by Stephen Riddle October 26, 2022
    by Stephen Riddle October 26, 2022

    Less than a week before Ipsen’s palovarotene was due to go in front of an…

    Read more
  • Pharma News

    It’s been a long time coming for long-term topical psoriasis treatments

    by Stephen Riddle October 26, 2022
    by Stephen Riddle October 26, 2022

    Psoriasis is a tricky disease to manage, as drawbacks and side effects loom with each…

    Read more
  • Pharma News

    Join the webinar: “Building Digital Therapeutics (DTx)” – case Orion

    by Stephen Riddle October 25, 2022
    by Stephen Riddle October 25, 2022

    Healthware, as the key R&D partner, has been supporting Orion Corporation to design and develop…

    Read more
  • Pharma News

    Syncona to acquire struggling AGTC for $23.5 million

    by Stephen Riddle October 25, 2022
    by Stephen Riddle October 25, 2022

    The healthcare company Syncona Limited has announced its newly established portfolio company is to acquire…

    Read more
  • Pharma News

    Astellas makes another gene therapy play, taking stake in Taysha

    by Stephen Riddle October 25, 2022
    by Stephen Riddle October 25, 2022

    Astellas has been having some safety-related issues with its gene therapy programmes of late, but…

    Read more
  • Pharma News

    Weak data for Fasenra undermine AZ’s ambitions for the drug

    by Stephen Riddle October 25, 2022
    by Stephen Riddle October 25, 2022

    AstraZeneca’s IL-5 inhibitor Fasenra is already making blockbuster sales from its use in eosinophilic asthma,…

    Read more
  • Pharma News

    Novartis drops presbyopia drug acquired with Encore Vision

    by Stephen Riddle October 25, 2022
    by Stephen Riddle October 25, 2022

    Novartis has abandoned development of its drug to treat presbyopia, a common age-related loss of…

    Read more
  • Pharma News

    The power of self-management to target gaps in chronic disease care

    by Stephen Riddle October 25, 2022
    by Stephen Riddle October 25, 2022

    The time of healthcare professionals is limited, but systems often rely on them as the…

    Read more
  • Pharma News

    Sumitomo ups ante and wins support for Myovant takeover

    by Stephen Riddle October 24, 2022
    by Stephen Riddle October 24, 2022

    A sweetened offer from Sumitomo Pharma has convinced endocrinology specialist Myovant to agree to a…

    Read more
  • Pharma News

    Novartis’ oral drug iptacopan tops injectables in head-to-head PNH trial

    by Stephen Riddle October 24, 2022
    by Stephen Riddle October 24, 2022

    Novartis has chalked up another clinical trial win for its targeted factor B inhibitor iptacopan…

    Read more
  • Pharma News

    Consolidation in psychedelics starts as Beckley and Eleusis combine

    by Stephen Riddle October 24, 2022
    by Stephen Riddle October 24, 2022

    Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics,…

    Read more
  • Pharma News

    AstraZeneca gets first FDA okay for CTLA4 drug tremelimumab

    by Stephen Riddle October 24, 2022
    by Stephen Riddle October 24, 2022

    AstraZeneca’s lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a…

    Read more
  • 1
  • 2
  • 3
  • 4
  • …
  • 34

Recent Posts

  • Ipsen’s Cabometyx recommended by NICE for previously treated HCC

    November 10, 2022
  • UK digital health firms join together on stroke care platform

    November 10, 2022
  • Clovis warns of insolvency as Rubraca goes into reverse

    November 10, 2022
  • Nordic Nanovector to merge with APIM after Betalutin fail

    November 10, 2022
  • ‘Healthcare shouldn’t be about treatment’: are diagnostics the answer to ending disease and virus outbreaks?

    November 10, 2022
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor

@2018 - TopPharmaNews.com. All Right Reserved.